Vertos Medical News Story

Innovator Spotlight: Vertos Plans to Expand Reach of Minimally Invasive Lumbar Decompression

Source— Medtech Insight Published June 1, 2019

This four-page article by Medtech Insight highlights the new professional consensus guidelines that recommend Vertos Medical’s minimally invasive lumbar decompression (mild®) system as an alternative to epidural steroid injections (ESIs) for patients with lumbar stenosis. It also mentions Vertos Medical’s plan to raise more capital to expand its commercial operation so it can reach more patients that may benefit from the mild® Procedure.

“In the near term, Vertos is trying to bring mild® to patients with lumbar stenosis who are not candidates for surgery and instead are being treated with epidural steroid injections (ESIs) as well as patients who still had significant symptoms after trying epidural steroid injections (ESIs). About 400,000 people in the US fit into this category annually, but the ultimate market for mild® is probably much bigger than that, according to (Eric) Wichems (Vertos Medical’s CEO),” the article states.

Read the full Medtech Insight article.

The views and opinions expressed in this article are those of the authors/speakers and do not necessarily reflect the official policy or position of Vertos Medical.


© 2024 Vertos Medical, Inc. All Rights Reserved.